Tibet Aim Pharm.Inc.’s Net Profit Rose 13.6% in First Three Quarters of 2023

Tibet Aim Pharm.Inc. (西藏易明西雅医药科技股份有限公司) (002826.SZ) reported a net profit of 24.4 million yuan in the first three quarters of 2023, up 13.6% year-on-year.

Meanwhile, the company posted 538.3 million yuan in revenue, down 9% year-on-year.

At the end of the reporting period, it had 1 billion yuan in total assets and 225 million yuan in total liabilities, with a liability-to-asset ratio of 22.9%.